Doceree announced the expansion of its targeted offering with Doceree ABM, account-based marketing (ABM) solution designed particularly for life science companies that allows them to contact institutional decision makers based on accounts and intent.
Doceree ABM enables marketers to target individual accounts or apply intent-based data to recognize the interest of institutional stakeholders, such as administrative decision-makers or healthcare professionals. It will improve the capacity of marketers to engage with qualified buyers who have shown interest in a product or category at the account level and monitor the account lift in real-time.
Harshit Jain MD, Founder & Global CEO, Doceree, said, "An ABM solution that's developed to be used across a multitude of industries neglects the intricacies that are associated with pursuing high-value accounts in the life sciences sector."
Harshit Jain MD, Founder & Global CEO, Doceree, said, "An ABM solution that's developed to be used across a multitude of industries neglects the intricacies that are associated with pursuing high-value accounts in the life sciences sector. Our programmatic platform provides innovative ABM capabilities to target decision makers based on their behavior to elevate interactions brands have with priority accounts when an individual is actively seeking a solution."
With the following features, Doceree ABM allows businesses to access institutional stakeholders at target accounts to enhance marketing and sales activities.
-
Account Targeting
-
Intent-based Targeting
Doceree launched the solution in North America and intended to expand its distribution to other worldwide regions.